» Articles » PMID: 28947563

Cardiovascular Benefits of Moderate Exercise Training in Marfan Syndrome: Insights From an Animal Model

Abstract

Background: Marfan syndrome (MF) leads to aortic root dilatation and a predisposition to aortic dissection, mitral valve prolapse, and primary and secondary cardiomyopathy. Overall, regular physical exercise is recommended for a healthy lifestyle, but dynamic sports are strongly discouraged in MF patients. Nonetheless, evidence supporting this recommendation is lacking. Therefore, we studied the role of long-term dynamic exercise of moderate intensity on the MF cardiovascular phenotype.

Methods And Results: In a transgenic mouse model of MF (), 4-month-old wild-type and MF mice were subjected to training on a treadmill for 5 months; sedentary littermates served as controls for each group. Aortic and cardiac remodeling was assessed by echocardiography and histology. The 4-month-old MF mice showed aortic root dilatation, elastic lamina rupture, and tunica media fibrosis, as well as cardiac hypertrophy, left ventricular fibrosis, and intramyocardial vessel remodeling. Over the 5-month experimental period, aortic root dilation rate was significantly greater in the sedentary MF group, compared with the wild-type group (∆mm, 0.27±0.07 versus 0.13±0.02, respectively). Exercise significantly blunted the aortic root dilation rate in MF mice compared with sedentary MF littermates (∆mm, 0.10±0.04 versus 0.27±0.07, respectively). However, these 2 groups were indistinguishable by aortic root stiffness, tunica media fibrosis, and elastic lamina ruptures. In MF mice, exercise also produced cardiac hypertrophy regression without changes in left ventricular fibrosis.

Conclusions: Our results in a transgenic mouse model of MF indicate that moderate dynamic exercise mitigates the progression of the MF cardiovascular phenotype.

Citing Articles

Exercise, Sports, and Cardiac Rehabilitation Recommendations in Patients with Aortic Aneurysms and Post-Aortic Repair: A Review of the Literature.

Stiefel M, Brito da Silva H, Schmied C, Niederseer D J Cardiovasc Dev Dis. 2024; 11(12).

PMID: 39728269 PMC: 11677462. DOI: 10.3390/jcdd11120379.


Angiotensin II-receptor blockers in bicuspid aortic valve patients with aortic dilation: Groping in the dark.

Meccanici F, Roos-Hesselink J Int J Cardiol Congenit Heart Dis. 2024; 10:100412.

PMID: 39713595 PMC: 11657548. DOI: 10.1016/j.ijcchd.2022.100412.


Online Personal Training in Patients With Marfan Syndrome: A Randomized Controlled Study of Its Impact on Quality of Life and Physical Capacity.

Jouini S, Milleron O, Eliahou L, Jondeau G, Vitiello D J Am Heart Assoc. 2024; 13(19):e033024.

PMID: 39291498 PMC: 11681478. DOI: 10.1161/JAHA.123.033024.


Management of aortic disease in children with FBN1-related Marfan syndrome.

Muino-Mosquera L, Cervi E, De Groote K, Dewals W, Fejzic Z, Kazamia K Eur Heart J. 2024; 45(39):4156-4169.

PMID: 39250726 PMC: 11472455. DOI: 10.1093/eurheartj/ehae526.


Clinical practice guidelines for the care of girls and women with Turner syndrome.

Gravholt C, Andersen N, Christin-Maitre S, Davis S, Duijnhouwer A, Gawlik A Eur J Endocrinol. 2024; 190(6):G53-G151.

PMID: 38748847 PMC: 11759048. DOI: 10.1093/ejendo/lvae050.


References
1.
Syyong H, Chung A, Yang H, van Breemen C . Dysfunction of endothelial and smooth muscle cells in small arteries of a mouse model of Marfan syndrome. Br J Pharmacol. 2009; 158(6):1597-608. PMC: 2795226. DOI: 10.1111/j.1476-5381.2009.00439.x. View

2.
Guasch E, Mont L . Diagnosis, pathophysiology, and management of exercise-induced arrhythmias. Nat Rev Cardiol. 2016; 14(2):88-101. DOI: 10.1038/nrcardio.2016.173. View

3.
Tae H, Petrashevskaya N, Marshall S, Krawczyk M, Talan M . Cardiac remodeling in the mouse model of Marfan syndrome develops into two distinctive phenotypes. Am J Physiol Heart Circ Physiol. 2015; 310(2):H290-9. PMC: 4747899. DOI: 10.1152/ajpheart.00354.2015. View

4.
Dietz H, Cutting G, Pyeritz R, Maslen C, Sakai L, Corson G . Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature. 1991; 352(6333):337-9. DOI: 10.1038/352337a0. View

5.
Schuler G, Adams V, Goto Y . Role of exercise in the prevention of cardiovascular disease: results, mechanisms, and new perspectives. Eur Heart J. 2013; 34(24):1790-9. DOI: 10.1093/eurheartj/eht111. View